Grandeur Peak Global Advisors’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-544,723
| Closed | -$24.4M | – | 116 |
|
|
2022
Q1 | $24.4M | Buy |
544,723
+206,266
| +61% | +$9.25M | 1.16% | 22 |
|
|
2021
Q4 | $14.5M | Buy |
338,457
+107,161
| +46% | +$4.59M | 0.66% | 29 |
|
|
2021
Q3 | $15.4M | Buy |
231,296
+16,078
| +7% | +$1.07M | 0.73% | 27 |
|
|
2021
Q2 | $15.8M | Buy |
215,218
+175,879
| +447% | +$12.9M | 0.75% | 27 |
|
|
2021
Q1 | $2.69M | Buy |
39,339
+30,520
| +346% | +$2.09M | 0.15% | 75 |
|
|
2020
Q4 | $592K | Hold |
8,819
| – | – | 0.03% | 101 |
|
|
2020
Q3 | $454K | Sell |
8,819
-2,081
| -19% | -$107K | 0.03% | 99 |
|
|
2020
Q2 | $411K | Sell |
10,900
-4,075
| -27% | -$154K | 0.03% | 100 |
|
|
2020
Q1 | $446K | Sell |
14,975
-17,250
| -54% | -$514K | 0.05% | 99 |
|
|
2019
Q4 | $1.11M | Sell |
32,225
-47,150
| -59% | -$1.62M | 0.1% | 76 |
|
|
2019
Q3 | $1.44M | Buy |
+79,375
| New | +$1.44M | 0.16% | 72 |
|